The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment decisions and outcomes for NCCN favorable intermediate-risk prostate cancer patients after receiving the 17-gene genomic prostate cancer score result.
 
Eric Margolis
Research Funding - Astellas Pharma; Ferring; Medtronic; Urovant Sciences
 
John Bennett
Employment - Genomic Health
Stock and Other Ownership Interests - Genomic Health
Research Funding - Genomic Health
 
Marina Pavlova
Employment - Genomic Health
Stock and Other Ownership Interests - Genomic Health
Research Funding - Genomic Health
 
Kenny Wong
Employment - Genomic Health
Stock and Other Ownership Interests - Genomic Health
Research Funding - Genomic Health
 
Christopher Michael Pieczonka
Employment - Associated Medical Professionals of New York
Leadership - Associated Medical Professionals of New York
Stock and Other Ownership Interests - Associated Medical Professionals of New York
Honoraria - Dendreon; Janssen
Consulting or Advisory Role - Dendreon; Janssen Oncology; Sun Pharma
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Merck; Merck; Pfizer; Sun Pharma
Research Funding - Advantagene; Astellas Pharma; AstraZeneca; Bayer; Dendreon; Innocrin Pharma; Janssen Oncology; Merck; Pfizer
 
Benjamin H. Lowentritt
Consulting or Advisory Role - Astellas Pharma; Dendreon; Janssen Oncology; Urogen pharma
Speakers' Bureau - Astellas Pharma; Bayer; Blue Earth Diagnostics; Clovis Oncology; Genomic Health; Janssen Oncology; Merck; Pfizer
Research Funding - Dendreon; Janssen Oncology; Myovant Sciences
 
Edward M. Uchio
Research Funding - Ambry Genetics; Bayer; Clovis Oncology; GenomeDx; Genomic Health; Janssen Oncology; Merck; Merit Medical Systems; Myovant Sciences; Myovant Sciences; Myriad Genetics; Pfizer
(OPTIONAL) Uncompensated Relationships - Bayer; Genomic Health; Janssen Oncology; Merck; Myriad Genetics; Pfizer
 
Melissa Conrad Stoppler
Employment - Genomic Health
Stock and Other Ownership Interests - Genomic Health
Research Funding - Genomic Health